Published in EMBO J on January 15, 2001
Diverse CD81 proteins support hepatitis C virus infection. J Virol (2006) 2.07
Hepatitis C virus E2 envelope glycoprotein core structure. Science (2013) 2.06
Three-dimensional model of the human platelet integrin alpha IIbbeta 3 based on electron cryomicroscopy and x-ray crystallography. Proc Natl Acad Sci U S A (2002) 1.93
Targeting of tetraspanin proteins--potential benefits and strategies. Nat Rev Drug Discov (2008) 1.91
Binding of the hepatitis C virus E2 glycoprotein to CD81 is strain specific and is modulated by a complex interplay between hypervariable regions 1 and 2. J Virol (2003) 1.89
Palmitoylation of tetraspanin proteins: modulation of CD151 lateral interactions, subcellular distribution, and integrin-dependent cell morphology. Mol Biol Cell (2002) 1.69
Claudin association with CD81 defines hepatitis C virus entry. J Biol Chem (2010) 1.67
Membrane budding. Cell (2010) 1.65
CD81 and claudin 1 coreceptor association: role in hepatitis C virus entry. J Virol (2008) 1.62
Identification of the hepatitis C virus E2 glycoprotein binding site on the large extracellular loop of CD81. J Virol (2002) 1.58
Tetraspanins in extracellular vesicle formation and function. Front Immunol (2014) 1.56
EWI-2 is a new component of the tetraspanin web in hepatocytes and lymphoid cells. Biochem J (2003) 1.50
Evidence for specific tetraspanin homodimers: inhibition of palmitoylation makes cysteine residues available for cross-linking. Biochem J (2004) 1.36
CLRN1 is nonessential in the mouse retina but is required for cochlear hair cell development. PLoS Genet (2009) 1.34
Structural basis for tetraspanin functions as revealed by the cryo-EM structure of uroplakin complexes at 6-A resolution. J Cell Biol (2006) 1.34
Laminin-binding integrins and their tetraspanin partners as potential antimetastatic targets. Expert Rev Mol Med (2010) 1.30
Lamprey lymphocyte-like cells express homologs of genes involved in immunologically relevant activities of mammalian lymphocytes. Proc Natl Acad Sci U S A (2002) 1.28
Assembly of urothelial plaques: tetraspanin function in membrane protein trafficking. Mol Biol Cell (2005) 1.27
Dissecting the role of putative CD81 binding regions of E2 in mediating HCV entry: putative CD81 binding region 1 is not involved in CD81 binding. Virol J (2008) 1.21
Structural organization and interactions of transmembrane domains in tetraspanin proteins. BMC Struct Biol (2005) 1.19
Complete predicted three-dimensional structure of the facilitator transmembrane protein and hepatitis C virus receptor CD81: conserved and variable structural domains in the tetraspanin superfamily. Biophys J (2006) 1.18
Tetraspanins in viral infections: a fundamental role in viral biology? J Virol (2005) 1.16
Recombinant extracellular domains of tetraspanin proteins are potent inhibitors of the infection of macrophages by human immunodeficiency virus type 1. J Virol (2006) 1.15
Hepatocyte permissiveness to Plasmodium infection is conveyed by a short and structurally conserved region of the CD81 large extracellular domain. PLoS Pathog (2008) 1.05
Tetraspanins as regulators of the tumour microenvironment: implications for metastasis and therapeutic strategies. Br J Pharmacol (2014) 1.01
Intron evolution: testing hypotheses of intron evolution using the phylogenomics of tetraspanins. PLoS One (2009) 1.00
Folding and subunit assembly of photoreceptor peripherin/rds is mediated by determinants within the extracellular/intradiskal EC2 domain: implications for heterogeneous molecular pathologies. J Biol Chem (2001) 0.98
Dissecting the diverse functions of the metastasis suppressor CD82/KAI1. FEBS Lett (2011) 0.98
High-level expression, single-step immunoaffinity purification and characterization of human tetraspanin membrane protein CD81. PLoS One (2008) 0.97
The absence of Tssc6, a member of the tetraspanin superfamily, does not affect lymphoid development but enhances in vitro T-cell proliferative responses. Mol Cell Biol (2002) 0.96
CD82 endocytosis and cholesterol-dependent reorganization of tetraspanin webs and lipid rafts. FASEB J (2009) 0.95
Targeting host factors: a novel rationale for the management of hepatitis C virus. World J Gastroenterol (2009) 0.93
Interacting regions of CD81 and two of its partners, EWI-2 and EWI-2wint, and their effect on hepatitis C virus infection. J Biol Chem (2011) 0.92
Determination of protein regions responsible for interactions of amelogenin with CD63 and LAMP1. Biochem J (2007) 0.92
Structural basis of ligand interactions of the large extracellular domain of tetraspanin CD81. J Virol (2012) 0.90
New treatments for chronic hepatitis C. Korean J Hepatol (2010) 0.89
Predicted and measured disorder in peripherin/rds, a retinal tetraspanin. Protein Pept Lett (2005) 0.87
Structural and functional analysis of the native peripherin-ROM1 complex isolated from photoreceptor cells. J Biol Chem (2013) 0.86
Structural characterization of recombinant human CD81 produced in Pichia pastoris. Protein Expr Purif (2007) 0.85
In silico directed mutagenesis identifies the CD81/claudin-1 hepatitis C virus receptor interface. Cell Microbiol (2012) 0.85
The extracellular δ-domain is essential for the formation of CD81 tetraspanin webs. Biophys J (2014) 0.84
CD81 and hepatitis C virus (HCV) infection. Viruses (2014) 0.84
Cysteine residues in the large extracellular loop (EC2) are essential for the function of the stress-regulated glycoprotein M6a. J Biol Chem (2009) 0.83
Interaction of hepatitis C virus envelope glycoprotein E2 with the large extracellular loop of tupaia CD81. World J Gastroenterol (2009) 0.83
Structural and functional analysis of the sarcoglycan-sarcospan subcomplex. Exp Cell Res (2006) 0.83
Ultrasonic imaging of endothelial CD81 expression using CD81-targeted contrast agents in in vitro and in vivo studies. Ultrasound Med Biol (2012) 0.82
Tetraspanins as therapeutic targets in hematological malignancy: a concise review. Front Physiol (2015) 0.81
Solution structure, membrane interactions, and protein binding partners of the tetraspanin Sm-TSP-2, a vaccine antigen from the human blood fluke Schistosoma mansoni. J Biol Chem (2014) 0.81
Role of conserved cysteine residues in hepatitis C virus glycoprotein e2 folding and function. J Virol (2012) 0.80
Mapping the binding between the tetraspanin molecule (Sjc23) of Schistosoma japonicum and human non-immune IgG. PLoS One (2011) 0.80
Toward atomic force microscopy and mass spectrometry to visualize and identify lipid rafts in plasmodesmata. Front Plant Sci (2014) 0.80
The evolution of vertebrate tetraspanins: gene loss, retention, and massive positive selection after whole genome duplications. BMC Evol Biol (2010) 0.80
Target-mediated drug disposition and prolonged liver accumulation of a novel humanized anti-CD81 monoclonal antibody in cynomolgus monkeys. MAbs (2013) 0.79
Distinct regions of the large extracellular domain of tetraspanin CD9 are involved in the control of human multinucleated giant cell formation. PLoS One (2014) 0.78
Oligomerization of the Tetraspanin CD81 via the Flexibility of Its δ-Loop. Biophys J (2016) 0.78
VH-VL orientation prediction for antibody humanization candidate selection: A case study. MAbs (2016) 0.78
A mutation in the human tetraspanin CD81 gene is expressed as a truncated protein but does not enable CD19 maturation and cell surface expression. J Clin Immunol (2015) 0.78
Structural characterization of the second intra-discal loop of the photoreceptor tetraspanin RDS. FEBS J (2012) 0.77
Tetraspanin CD151 Promotes Initial Events in Human Cytomegalovirus Infection. J Virol (2016) 0.77
Expression and structural characterization of peripherin/RDS, a membrane protein implicated in photoreceptor outer segment morphology. Eur Biophys J (2009) 0.76
Role of Conserved E2 Residue W420 in Receptor Binding and Hepatitis C Virus Infection. J Virol (2016) 0.76
Molecular characterization of Clonorchis sinensis tetraspanin 2 extracellular loop 2. Parasitol Res (2011) 0.76
Molecular cloning, sequence characterization and expression analysis of a CD63 homologue from the coleopteran beetle, Tenebrio molitor. Int J Mol Sci (2013) 0.76
Expression and Subcellular Distribution of GFP-Tagged Human Tetraspanin Proteins in Saccharomyces cerevisiae. PLoS One (2015) 0.76
A view of the E2-CD81 interface at the binding site of a neutralizing antibody against hepatitis C virus. J Virol (2014) 0.75
The Emerging Role of Tetraspanins in the Proteolytic Processing of the Amyloid Precursor Protein. Front Mol Neurosci (2016) 0.75
An optimized hepatitis C virus E2 glycoprotein core adopts a functional homodimer that efficiently blocks virus entry. J Virol (2016) 0.75
The specificity of homomeric clustering of CD81 is mediated by its δ-loop. FEBS Open Bio (2017) 0.75
TETRASPANINs in Plants. Front Plant Sci (2017) 0.75
The C Isoform of Dictyostelium Tetraspanins Localizes to the Contractile Vacuole and Contributes to Resistance against Osmotic Stress. PLoS One (2016) 0.75
Tspan2: a tetraspanin protein involved in oligodendrogenesis and cancer metastasis. Biochem Soc Trans (2017) 0.75
CD63 Promotes Hemocyte-Mediated Phagocytosis in the Clam, Paphia undulata. J Immunol Res (2016) 0.75
Tetraspanins Function as Regulators of Cellular Signaling. Front Cell Dev Biol (2017) 0.75
Identification of ligands that target the HCV-E2 binding site on CD81. J Comput Aided Mol Des (2013) 0.75
The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr (1994) 187.88
The Protein Data Bank. Nucleic Acids Res (2000) 187.10
Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr (1998) 169.28
Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr (1997) 137.43
Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A (1991) 119.63
Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins (1991) 36.69
Protein structure comparison by alignment of distance matrices. J Mol Biol (1993) 34.74
Raster3D Version 2.0. A program for photorealistic molecular graphics. Acta Crystallogr D Biol Crystallogr (1994) 17.44
Binding of hepatitis C virus to CD81. Science (1998) 12.40
Methods used in the structure determination of bovine mitochondrial F1 ATPase. Acta Crystallogr D Biol Crystallogr (1996) 11.90
The tetraspanin superfamily: molecular facilitators. FASEB J (1997) 4.29
CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. Annu Rev Immunol (1998) 4.01
A synthetic IgG-binding domain based on staphylococcal protein A. Protein Eng (1989) 3.31
A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. Proc Natl Acad Sci U S A (1996) 3.25
Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2. J Virol (2000) 2.71
Structure-function analysis of hepatitis C virus envelope-CD81 binding. J Virol (2000) 2.32
A model for the hepatitis C virus envelope glycoprotein E2. Proteins (2000) 2.17
Integrin associated proteins. Curr Opin Cell Biol (1998) 2.17
CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrins. Eur J Immunol (1996) 2.10
Characterization of novel complexes on the cell surface between integrins and proteins with 4 transmembrane domains (TM4 proteins). Mol Biol Cell (1996) 1.94
Selective tetraspan-integrin complexes (CD81/alpha4beta1, CD151/alpha3beta1, CD151/alpha6beta1) under conditions disrupting tetraspan interactions. Biochem J (1999) 1.72
Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection. J Virol (2000) 1.70
Direct extracellular contact between integrin alpha(3)beta(1) and TM4SF protein CD151. J Biol Chem (2000) 1.69
The tetraspan protein CD82 is a resident of MHC class II compartments where it associates with HLA-DR, -DM, and -DO molecules. J Immunol (1998) 1.69
Integrin modulation by lateral association. J Biol Chem (2000) 1.16
Cell surface monkey CD9 antigen is a coreceptor that increases diphtheria toxin sensitivity and diphtheria toxin receptor affinity. J Biol Chem (2000) 0.94
Crystallization and preliminary crystallographic studies on the large extracellular domain of human CD81, a tetraspanin receptor for hepatitis C virus. Acta Crystallogr D Biol Crystallogr (2001) 0.86
The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature (1997) 33.47
Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. Science (2000) 16.04
Binding of hepatitis C virus to CD81. Science (1998) 12.40
Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci U S A (1993) 11.85
Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science (2000) 7.41
Two conserved sequence blocks within eukaryotic tRNA genes are major promoter elements. Nature (1981) 6.20
Conformational alteration of mRNA structure and the posttranscriptional regulation of erythromycin-induced drug resistance. Nucleic Acids Res (1980) 4.09
The cDNA sequences of the sea urchin U7 small nuclear RNA suggest specific contacts between histone mRNA precursor and U7 RNA during RNA processing. EMBO J (1984) 3.36
Biochemical complementation with RNA in the Xenopus oocyte: a small RNA is required for the generation of 3' histone mRNA termini. Cell (1983) 3.36
Human monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognize conserved conformational epitopes. J Virol (2000) 3.26
A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. Proc Natl Acad Sci U S A (1996) 3.25
Antigen-independent activation of naive and memory resting T cells by a cytokine combination. J Exp Med (1994) 2.56
Posttranscriptional regulation of an erythromycin resistance protein specified by plasmic pE194. Proc Natl Acad Sci U S A (1980) 2.47
Sequence and analysis of the genetic locus responsible for surfactin synthesis in Bacillus subtilis. Mol Microbiol (1993) 2.35
Structure-function analysis of hepatitis C virus envelope-CD81 binding. J Virol (2000) 2.32
Three-dimensional structure of the tetragonal crystal form of egg-white avidin in its functional complex with biotin at 2.7 A resolution. J Mol Biol (1993) 2.18
Refined crystal structure of ascorbate oxidase at 1.9 A resolution. J Mol Biol (1992) 2.18
T cells can present antigens such as HIV gp120 targeted to their own surface molecules. Nature (1988) 2.15
Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant. Infect Immun (1996) 2.14
Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Heggllin/Fechtner Syndrome Consortium. Nat Genet (2000) 2.08
Detection in an enzyme immunoassay of an immune response to a recombinant fragment of the 128 kilodalton protein (CagA) of Helicobacter pylori. Eur J Clin Microbiol Infect Dis (1993) 2.02
Sexual transmission of the hepatitis C virus and efficacy of prophylaxis with intramuscular immune serum globulin. A randomized controlled trial. Arch Intern Med (1997) 1.92
Structure and bactericidal activity of an antibiotic dodecapeptide purified from bovine neutrophils. J Biol Chem (1988) 1.91
X-ray crystal structure of the blue oxidase ascorbate oxidase from zucchini. Analysis of the polypeptide fold and a model of the copper sites and ligands. J Mol Biol (1989) 1.90
Dissociation of water under pressure. Phys Rev Lett (2001) 1.90
Compartmentalization of T lymphocytes to the site of disease: intrahepatic CD4+ T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C. J Exp Med (1993) 1.90
Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity. J Clin Invest (2001) 1.84
Introduction of unmarked mutations in the Helicobacter pylori vacA gene with a sucrose sensitivity marker. Infect Immun (1997) 1.82
Renal vasoconstriction in cirrhosis evaluated by duplex Doppler ultrasonography. Hepatology (1993) 1.69
Crystal structure of D-amino acid oxidase: a case of active site mirror-image convergent evolution with flavocytochrome b2. Proc Natl Acad Sci U S A (1996) 1.68
Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co-stimulatory signal for human T cells. Eur J Immunol (2001) 1.67
Translational attenuation of ermC: a deletion analysis. Mol Gen Genet (1982) 1.65
Helicobacter pylori toxin VacA induces vacuole formation by acting in the cell cytosol. Mol Microbiol (1997) 1.60
Transcriptional activation of the cholesterol 7alpha-hydroxylase gene (CYP7A) by nuclear hormone receptors. J Lipid Res (1998) 1.60
Recombinant human monoclonal antibodies against different conformational epitopes of the E2 envelope glycoprotein of hepatitis C virus that inhibit its interaction with CD81. J Gen Virol (2000) 1.55
Nutritional and prognostic significance of insulin-like growth factor 1 in patients with liver cirrhosis. Nutrition (1997) 1.54
Dynamics of intra-hepatic lymphocytes in chronic hepatitis C: enrichment for Valpha24+ T cells and rapid elimination of effector cells by apoptosis. Eur J Immunol (1998) 1.54
The Helicobacter pylori neutrophil-activating protein is an iron-binding protein with dodecameric structure. Mol Microbiol (1999) 1.53
Characterization of the syringomycin synthetase gene cluster. A link between prokaryotic and eukaryotic peptide synthetases. J Biol Chem (1998) 1.52
High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C. Hepatology (1998) 1.50
Disposition of metformin (N,N-dimethylbiguanide) in man. Clin Pharmacol Ther (1978) 1.50
Conserved patterns in the Cu,Zn superoxide dismutase family. J Mol Biol (1994) 1.49
A persulfurated cysteine promotes active site reactivity in Azotobacter vinelandii Rhodanese. Biol Chem (2001) 1.47
Different specific activities of the monomeric and oligomeric forms of plasmid DNA in transformation of B. subtilis and E. coli. Mol Gen Genet (1979) 1.45
Malignant mesothelioma of the pleura among seafarers. Med Lav (2006) 1.43
Latency periods in asbestos-related mesothelioma of the pleura. Eur J Cancer Prev (1997) 1.43
Sputum processing: a new method to improve cytospin quality. Clin Exp Allergy (2002) 1.41
Hepatic left lobe volume is a sensitive index of metabolic improvement in obese women after gastric banding. Int J Obes (Lond) (2011) 1.41
The crystal structure of a sulfurtransferase from Azotobacter vinelandii highlights the evolutionary relationship between the rhodanese and phosphatase enzyme families. J Mol Biol (2000) 1.40
Molecular analysis of V(H)I+ B lymphocytes in hepatitis C patients. Dig Liver Dis (2003) 1.40
Assessment of chemokine receptor expression by human Th1 and Th2 cells in vitro and in vivo. J Leukoc Biol (1999) 1.40
Helicobacter pylori-specific CD4+ T-cell clones from peripheral blood and gastric biopsies. Infect Immun (1995) 1.39
Hypophosphatemia and renal tubular dysfunction in alcoholics. Are they related to liver function impairment? Gastroenterology (1991) 1.39
Updating prognosis of cirrhosis by Cox's regression model using Child-Pugh score and aminopyrine breath test as time-dependent covariates. Ital J Gastroenterol Hepatol (1998) 1.39
Presence of effector CD8+ T cells in hepatitis C virus-exposed healthy seronegative donors. J Immunol (1999) 1.39
Characterization of human monoclonal antibodies specific to the hepatitis C virus glycoprotein E2 with in vitro binding neutralization properties. Virology (1998) 1.37
Regulation of extracellular matrix synthesis by transforming growth factor beta 1 in human fat-storing cells. Gastroenterology (1993) 1.35
Nonvertebrate hemoglobins: structural bases for reactivity. Prog Biophys Mol Biol (1997) 1.34
Mycobacterium tuberculosis hemoglobin N displays a protein tunnel suited for O2 diffusion to the heme. EMBO J (2001) 1.33
Crystal structure of the trigonal form of bovine beta-lactoglobulin and of its complex with retinol at 2.5 A resolution. J Mol Biol (1987) 1.33
A novel two-over-two alpha-helical sandwich fold is characteristic of the truncated hemoglobin family. EMBO J (2000) 1.31
The fate of the 15-beta hydrogen of lanosterol in cholesterol biosynthesis. J Am Chem Soc (1968) 1.30
Life, activation and death of intrahepatic lymphocytes in chronic hepatitis C. Immunol Rev (2000) 1.30
Naturally occurring macrolide-lincosamide-streptogramin B resistance in Bacillus licheniformis. J Bacteriol (1981) 1.28
How many water molecules can be detected by protein crystallography? Acta Crystallogr D Biol Crystallogr (1999) 1.26
Antibodies as antigens. The use of mouse monoclonal antibodies to focus human T cells against selected targets. J Exp Med (1988) 1.25
Left ventricular diastolic function in liver cirrhosis. Scand J Gastroenterol (1996) 1.25
The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology (2000) 1.24
Bone marrow transplantation from unrelated donors: the impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain. Blood (2001) 1.24
Unusual structure of the oxygen-binding site in the dimeric bacterial hemoglobin from Vitreoscilla sp. Structure (1997) 1.23
Neonatal invariant Valpha24+ NKT lymphocytes are activated memory cells. Eur J Immunol (2000) 1.23
Cloning of a novel pilin-like gene from Bordetella pertussis: homology to the fim2 gene. Mol Microbiol (1988) 1.21
Dissection of human humoral immune response against hepatitis C virus E2 glycoprotein by repertoire cloning and generation of recombinant Fab fragments. Hepatology (1998) 1.21
Evidence for the biological conversion of delta 8,14 sterol dienes into cholesterol. J Am Chem Soc (1968) 1.20
Mass spectrometric investigations of some unsaturated sterols biosynthetically related to cholesterol. Steroids (1967) 1.18
Characterization of the srfA locus of Bacillus subtilis: only the valine-activating domain of srfA is involved in the establishment of genetic competence. Mol Microbiol (1993) 1.17
Malnutrition in alcoholic and virus-related cirrhosis. Am J Clin Nutr (1996) 1.16
Kinetic and crystallographic analyses support a sequential-ordered bi bi catalytic mechanism for Escherichia coli glucose-1-phosphate thymidylyltransferase. J Mol Biol (2001) 1.16
Crystal structure of NH3-dependent NAD+ synthetase from Bacillus subtilis. EMBO J (1996) 1.16
The allosteric regulation of pyruvate kinase. FEBS Lett (1996) 1.15
Gene expression profile in Neisseria meningitidis and Neisseria lactamica upon host-cell contact: from basic research to vaccine development. Ann N Y Acad Sci (2002) 1.14
Transcriptional regulation of the human cholesterol 7 alpha-hydroxylase gene (CYP7A) in HepG2 cells. J Lipid Res (1996) 1.13
Active site plasticity in D-amino acid oxidase: a crystallographic analysis. Biochemistry (1997) 1.13
Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Hepatology (2000) 1.13
Chronic sleep deprivation and seasonality: implications for the obesity epidemic. J Endocrinol Invest (2011) 1.12
Virus-specific CD8(+) T cells with type 1 or type 2 cytokine profile are related to different disease activity in chronic hepatitis C virus infection. Eur J Immunol (2001) 1.12